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Method

Spatiotemporal clustering of the epigenome reveals
rules of dynamic gene regulation
Pengfei Yu,1,2,5 Shu Xiao,1,2,5 Xiaoyun Xin,3,6 Chun-Xiao Song,4,6 Wei Huang,2,6
Darina McDee,2 Tetsuya Tanaka,2 Ting Wang,3 Chuan He,4 and Sheng Zhong1,2,7
1

Department of Bioengineering, University of California, San Diego, California 92093, USA; 2Institute for Genomic Biology, University
of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA; 3Department of Genetics, Washington University in St. Louis,
St. Louis, Missouri 63108, USA; 4Department of Chemistry, University of Chicago, Chicago, Illinois 60637, USA
Spatial organization of different epigenomic marks was used to infer functions of the epigenome. It remains unclear what
can be learned from the temporal changes of the epigenome. Here, we developed a probabilistic model to cluster genomic
sequences based on the similarity of temporal changes of multiple epigenomic marks during a cellular differentiation
process. We differentiated mouse embryonic stem (ES) cells into mesendoderm cells. At three time points during this
differentiation process, we used high-throughput sequencing to measure seven histone modifications and variants—H3K4me1/2/3, H3K27ac, H3K27me3, H3K36me3, and H2A.Z; two DNA modifications—5-mC and 5-hmC; and
transcribed mRNAs and noncoding RNAs (ncRNAs). Genomic sequences were clustered based on the spatiotemporal
epigenomic information. These clusters not only clearly distinguished gene bodies, promoters, and enhancers, but also
were predictive of bidirectional promoters, miRNA promoters, and piRNAs. This suggests specific epigenomic patterns
exist on piRNA genes much earlier than germ cell development. Temporal changes of H3K4me2, unmethylated CpG, and
H2A.Z were predictive of 5-hmC changes, suggesting unmethylated CpG and H3K4me2 as potential upstream signals
guiding TETs to specific sequences. Several rules on combinatorial epigenomic changes and their effects on mRNA expression and ncRNA expression were derived, including a simple rule governing the relationship between 5-hmC and gene
expression levels. A Sox17 enhancer containing a FOXA2 binding site and a Foxa2 enhancer containing a SOX17 binding site
were identified, suggesting a positive feedback loop between the two mesendoderm transcription factors. These data
illustrate the power of using epigenome dynamics to investigate regulatory functions.
[Supplemental material is available for this article.]
An epigenome consists of chemical modifications and protein
variations to the DNA and histones, and some of these modifications and variations can be passed down to an organism’s offspring
(Bernstein et al. 2007). Epigenomes are dynamic, and epigenetic
modifications are associated with changes in gene expression
(Creyghton et al. 2010; Hawkins et al. 2011). Thus, the epigenome
adds an extra layer of information onto the genomic sequence and
enables a genome to dynamically orchestrate gene expression in
different cell types (Karlic et al. 2010; Maunakea et al. 2010). It is
argued that organismal development can be viewed as a progression of epigenomic states (Bernstein et al. 2007; Hawkins et al.
2010). To gain mechanistic support for this view, a number of
challenges have to be addressed. First, when presented with genome-wide distributions of epigenetic modifications at multiple
time points during a developmental or differentiation process,
how can we find the genomic (cis-) regulatory sequences that
regulate gene expression? What are the combinatorial functions of
epigenetic modifications and regulatory sequences? Here, we
present experimental data and a probabilistic model that utilizes
the temporal changes of the epigenome to annotate the regulatory sequences. This approach classifies regulatory sequences
by their temporal epigenomic patterns, and thus it can identify
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subclasses of cis-regulatory sequences with different regulatory
functions.
Two types of associations were observed between the epigenome and gene expression. First, in a given cell type, the transcription levels of different genes are associated with the epigenomic modifications in the genomic neighborhoods of these
genes. In other words, without changing cell types, epigenomic
modifications at different chromosomal locations are indicative of
the relative abundance of RNAs transcribed from these locations
(Fig. 1A, spatial correlation [S]; Karlic et al. 2010). Second, for
a given gene, the temporal change in its expression during a developmental or differentiation process is associated with temporal
epigenomic changes (Fig. 1A, temporal correlation [T]; RadaIglesias et al. 2011). The first type of association facilitated the use
of invariant epigenomic signatures in a static cellular condition to
annotate genomic features (Ernst and Kellis 2010). However, genes
are dynamically regulated in nearly all biological processes. It is
important to incorporate the dynamic aspect of gene regulation
into the annotation of the regulatory sequences. Here, we jointly
model the position effect and the temporal effect of the epigenome, thus achieving ab initio identification and functional
annotation of regulatory sequences.
The regulatory functions of a number of epigenetic modifications remain elusive. A case in point is DNA hydroxymethylation (Wyatt and Cohen 1952). Methylated cytosine
(5-mC) can be converted to an oxidized form 5-hydroxymethylcytosine (5-hmC) by a family of ten-eleven translocation
(TET) proteins (Tahiliani et al. 2009; Ito et al. 2010). In embryonic
stem (ES) cells, 5-hmC is enriched in gene bodies of actively tran-
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Spatiotemporal clustering of the epigenome

Figure 1. The genomic annotation based on the time-course epigenomic data (GATE) model. (A) Two types of correlations between the
epigenome and gene expression. Spatial correlation (S) examines different genes in a fixed cell type, and temporal correlation (T) examines
different differentiation stages or cell types for a fixed gene. Spatial correlation is often much more pronounced than temporal correlation. (B–C )
GATE models the genome as equal-sized genomic segments, and each
segment is associated with temporal epigenomic data. The model assumes that there are shared temporal epigenomic patterns among different genomic segments. GATE is a hierarchical model. The top layer is
a finite mixture model for clustering genomic segments. The bottom layer
models the temporal changes within each cluster as a hidden Markov
model. The hidden variables (circles) are binary variables, indicating the
time of a change of regulatory activities. Emitted (vertical arrows) from the
hidden variable are the intensities of each epigenomic mark.

beyond the co-appearance in static cell types are needed. A natural
extension in this direction is to utilize a dynamic process in which
both the epigenome and the transcriptome have changes. Ideally,
we need some methods that can capture combinatorial patterns of
temporal epigenomic changes and correlate them with gene expression changes.
A major difficulty in analyzing epigenomic dynamics lies in
the asynchronous nature of epigenomic changes in different genomic regions. Suppose a type of epigenomic change, for example,
the induction of H3K4me1 and 5-hmC, is a recurring pattern
shared by many genomic regions. Such a pattern can be difficult to
find because different genomic regions can accumulate either
modification at different times. Furthermore, the corresponding
changes in gene expression are not synchronized, making it difficult to associate epigenomic dynamics with gene expression
changes. To reveal the hidden rules of epigenomic dynamics
and gene expression, we developed a spatiotemporal clustering
model. This model clusters genomic regions by shared epigenomic
changes but does not require the changes to be synchronized
among a cluster of genomic regions. This was achieved by allowing
each region to have its own time-specific epigenomic states and then
integrating out the time of transition between the epigenomic
states in the clustering model.
To investigate the functions of epigenetic modifications in
a dynamic process, we differentiated mouse ES cells into mesendoderm cells (Yasunaga et al. 2005), the common precursor of
mesoderm and endoderm. At three time points during this differentiation process, we mapped the genomic distributions of nine
epigenetic modifications, including DNA methylation (5-mC),
hydroxymethylation (5-hmC), histone variant H2A.Z, and histone
modifications H3K4me1, H3K4me3, H3K27ac, H3K27me3, and
H3K36me3. At the same time points, we also assayed the expression of small noncoding RNAs (ncRNAs) and total RNAs (Supplemental Fig. S1). Our model-based analysis of these temporal data
revealed several fundamental properties of epigenome dynamics,
characterizing regulatory roles for functionally elusive epigenomic
modifications. As an analogy to the sequence ‘‘rules’’ of gene regulation (Buchler et al. 2003; Beer and Tavazoie 2004), these discoveries may provide epigenomic ‘‘rules’’ of gene regulation.

Results
A model for genome annotation using temporal
epigenomic data

scribed genes (Wu et al. 2011a), promoters of inactive genes (Ficz
et al. 2011; Pastor et al. 2011; Wu et al. 2011a), and active enhancers (Stroud et al. 2011). These seemingly conflicting data are
thought-provoking for analyzing epigenetic modifications in a
combinatorial manner, such that the function of each modification is investigated in the context of other modifications as well as
the underlying genomic sequence. By modeling the co-appearance
of different epigenetic modifications in each cell type, a pioneering
method demonstrated the power in predicting different genomic
features, including enhancers and genes (Ernst and Kellis 2010).
However, epigenomic co-appearance in static cell types does not
reveal all epigenetic mechanisms of gene regulation. Two major
questions remain unsolved. First, what are the upstream signals
that guide specific epigenomic modifications, such as 5-hmC, to
appear in specific genomic regions? Second, the regulatory functions for several epigenomic marks, including 5-hmC and H2A.Z,
remain elusive. New ideas for combinatorial epigenomic analyses

We developed a probabilistic model to annotate the genome using
temporal epigenomic data. Two main features of this model include explicit treatment of combinatorial epigenomic changes and
detecting similar but asynchronous epigenomic changes in different genomic segments.
As input data to the model, the genome is represented as
consecutive genomic segments, with a typical segment size of 200
nucleotides (nt) (for the impact of segment sizes, see Supplemental
Fig. S5). Each segment is associated with the time-specific intensities of a set of epigenetic modifications. The model clusters
the genomic segments, such that each cluster shares a similar
combination of epigenetic modifications as well as their temporal
changes. We call the combination of epigenetic modifications
shared by a cluster of genomic segments at a given time an epigenomic state. Each cluster represents a time-series of related epigenomic states. Essentially this model assigns epigenomic states
based on time-series epigenomic data.
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We call this model genomic annotation using temporal epigenomic data (GATE). GATE is a hierarchical model (Pearl 1985)
with two layers (Fig. 1B). The top layer is a finite mixture model
(FMM) (Equihua 1988), in which each component of the mixture
represents a cluster of genomic segments that share temporal epigenomic patterns. Without considering the time factor, each
component (cluster) degenerates into a set of genomic segments
sharing an epigenomic state. The bottom layer models the epigenomic data in each cluster. Each cluster is modeled as a hidden
Markov model (HMM) (Durbin et al. 1998) that represents the
temporal changes of epigenetic modification intensities. The hidden states are binary activity states (inactive and active), which are
allowed to change with respect to time. For example, if an enhancer changes from an active enhancer into an inactive enhancer
during differentiation, the hidden states for this enhancer would
change from 0 (inactive) to 1 (active). In a differentiation process,
state 0 can be interpreted as the initial state before differentiation
(undifferentiated [U]), whereas state 1 can be regarded as the other
state in differentiated cells (differentiated [D]). The observed data
are the epigenetic modification intensities for each genomic segment at every time point (Fig. 1B). The sequencing reads from
chromatin immunoprecipitation followed by sequencing (ChIPseq) experiments for each epigenetic modification on a genomic
segment are modeled with a Poisson distribution, with the Poisson
parameter reflecting the cluster and time-dependent epigenomic
state. Thus, GATE has been completely specified as a generative
probabilistic model (see Methods). In short, GATE is a finite mixture of HMMs. Distinguishing itself from a previous method that
predicts chromatin states based on static epigenetic data (Ernst
and Kellis 2010), GATE models epigenomic data as a dynamic
continuum and directly utilizes temporal information to annotate epigenomic states. This feature facilitates the discovery of cisregulatory sequences and the annotation of their regulatory
functions (Supplemental Fig. S6).
We implemented an expectation–maximization (EM) method
(Dempster et al. 1977) to estimate model parameters from data
(Supplemental Fig. S1; Supplemental Methods). At every maximization step, we embedded a Baum-Welch algorithm (Durbin et al.
1998) to estimate the HMM parameters. We provide GATE as a fully
documented program at http://biocomp.bioen.uiuc.edu/GATE.
GATE was tested with simulated cell differentiation processes
(Supplemental Data 1; Supplemental Tables S2–S4).

Epigenomic landscape during the differentiation of ES cells
to mesendoderm
Mesendoderm is the diverging point of definitive endoderm and
mesoderm (Yasunaga et al. 2005), which represents an important
cell lineage besides the neural lineage (ectoderm) during the early
stages of ES cell differentiation. We differentiated mouse ES cells to
mesendoderm using Activin and a previously described culture
medium (Yasunaga et al. 2005). On the sixth day of differentiation,
almost all cells exhibited typical mesendoderm morphology and
expressed mesendoderm protein Goosecoid (GSC) (Blum et al.
1992) and endoderm protein SOX17 (Supplemental Fig. S2A; KanaiAzuma et al. 2002). Pluripotency genes Pou5f1(also known as Oct4),
Sox2, and Nanog were down-regulated, whereas endoderm and
mesoderm genes Gsc, Chordin, Foxa2, Sox17, Lim1, and Hnf4 were
up-regulated (Supplemental Fig. S2B).
We measured a total of nine epigenomic marks at three time
points (day 0, 4, and 6) during the differentiation process. These
marks included seven histone modifications or variants (H3K4me1/
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2/3, H3K27ac, H3K27me3, H3K36me3, and H2A.Z), which were
assayed by ChIP-seq (Xiao et al. 2012). We supplemented the histone data with two types of DNA modifications, including 5-hmC
by chemical labeling and pull-down followed by sequencing
(5-hmC-seq) (Song et al. 2011) and 5-mC by both methylated DNA
immunoprecipitation followed by sequencing (MeDIP-seq) and
DNA digestion by methyl-sensitive restriction enzymes followed
by sequencing (MRE-seq) (Maunakea et al. 2010). The 5-hmC pulldown specifically used the chemical property of the hydroxyl-group
and thus was efficient to distinguish 5-hmC from 5-mC (Song et al.
2011). MeDIP-seq was representative of 5-mC, and MRE-seq was representative of unmethylated CpGs (uCpGs) (Maunakea et al. 2010).
To analyze the transcriptome, we sequenced ncRNAs using
the Illumina Small RNA Sample Preparation procedure followed by
sequencing (Illumina 2010b) and mRNAs using RNA-seq (Mortazavi
et al. 2008) at the same three time points. Taken together, 36 sequencing data sets composed of 1.94 billion 75-nt or 100-nt
uniquely alignable sequencing reads were generated.
These data allowed us to estimate that 11.5% of the mouse genome is associated with at least one type of epigenetic modification
in undifferentiated ES cells. Nearly half of these regions (5.60% of the
genome) exhibited significant changes in at least one epigenetic
modification during differentiation. About 1.92% of the genome was
transcribed into mRNAs in ES cells, and 0.43% of the genome
exhibited change of mRNA expression levels during differentiation.

Spatiotemporal clustering of epigenomic states
GATE clusters genomic segments based on both spatial distributions of epigenomic modifications and temporal changes of these
modifications. Applying GATE to the ‘‘ES cell to mesendoderm’’
differentiation data set, we initially obtained 55 clusters, consistent with the previously estimated number of chromatin states
(Ernst and Kellis 2010). These clusters formed 14 larger groups
(Supplemental Fig. S3). Twelve of the 14 groups showed epigenomic characteristics that are typical to gene bodies, promoters,
and enhancers. For example, groups 2, 3, 6, and 9 shared enhancer
characteristics, including low H3K36me3, high H3K4me1 in either
undifferentiated (Fig. 2A, U) or differentiated states (D), and either
high H3K27me3 or high H3K27ac (Fig. 2, vertical green bar).
Groups 1b, 5, 8, and 12 shared promoter characteristics, including high H3K4me3 and low H3K36me3 (red bar). Groups 1a, 4, 10,
and 11 shared high levels of H3K36me3, which was associated
with gene bodies (Fig. 2, blue bar; Kolasinska-Zwierz et al. 2009;
Schwartz et al. 2009).
By assigning clusters as promoter, enhancer, gene body, and
repeat clusters (Fig. 2, red, green, blue, and gray bars), we turned
the unsupervised spatiotemporal epigenomic clusters into predictions of different genomic features. To check these predictions,
we compared the locations of the genomic segments in every
cluster to their nearest genes. Indeed, the relative locations of genomic segments in each cluster corroborated the unsupervised
predictions (Supplemental Fig. S4). Chromosome 11 was randomly
chosen for quantifying the prediction accuracies. The sensitivities
for detecting promoters increased from 0% to 60% when the falsepositive rate (1  specificity) increased from 0% to 0.25% (Fig. 3B).
Similar tradeoffs between sensitivity and specificity were found for
gene body predictions (Fig. 3C). These quantities reinforced the visual
impression (Supplemental Fig. S4) that spatiotemporal clusters correlate with different genomic features. Changing the input size of
genomic segments from 200 nt to 100 nt did not change any qualitative characteristics of the clustering results (Supplemental Fig. S5).

Spatiotemporal clustering of the epigenome

Figure 2. Epigenomic clusters. (A) Average intensities of each epigenomic mark (column) in each cluster (row). The model allows each sequence
segment to have two activity states, denoted as undifferentiated (U) and differentiated (D). The model assumes that each cluster has a shared mean
intensity for each epigenomic mark at either activity state. These mean intensities are plotted in this matrix and are color-coded. Clusters with similar
intensities were merged into larger clusters (groups) (for the merging procedure, see Supplemental Fig. S3). Based on the epigenomic patterns, the groups were
assigned with representative names, including promoters, enhancers, genes, and repeats (vertical color bars). Consistent intensity changes across multiple
clusters in a group are highlighted (red circles). (B) Fold enrichment of genomic and epigenomic features (column) in each cluster (row). Fold enrichment was
calculated as the ratio between the average signal of a cluster to the average signal of all clusters. mRNA indicates transcription levels of nearest genes, derived
from RNA-seq data; ncRNA, transcription levels of the genomic segment in each cluster, derived from ncRNA-seq data; CpG, CpG density; P300, EP300 (also
known as p300) binding intensity; PolII, PolII binding intensity; and repeats, repeat density. Significant temporal changes are highlighted (orange circles).

Spatiotemporal epigenomic clusters are predictive
of transposons, bidirectional promoters, microRNA
promoters, and PIWI RNAs
Not only did the spatiotemporal epigenomic clusters predict usual
genomic features such as enhancers, promoters, and gene bodies,
unexpectedly these clusters were also capable of predicting genomic features, including repeats, bidirectional promoters (Lin et al.
2007; Hakkinen et al. 2011), microRNA (miRNA) promoters (Marson
et al. 2008), and PIWI RNAs (piRNAs) (Thomson and Lin 2009).

Two groups (groups 13 and 14) exhibited unfamiliar epigenomic characteristics, including high H3K36me3 in parallel
with high H3K27me3. These clusters did not locate in gene bodies
or promoters (Supplemental Fig. S4). They contained the highest
proportions of repeats among all 55 clusters (P = 5.45 3 1037,
Fisher’s exact test) (Fig. 2B, ‘‘repeats’’ column). ncRNA expression
showed that groups 13 and 14 corresponded to transcribed and
silenced repeat sequences (Fig. 2B, ncRNA). These data suggest
a distinct spatiotemporal epigenomic signature for repeats and
transposons.
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though piRNAs were produced and functional in germ cells, specific epigenomic
patterns were formed on piRNA genes
much earlier than germ cell development. PiRNA genes may be epigenetically
prepared for activation in ES cells.
The distinct epigenomic characteristics in ES cells opened the possibility
that a subset of piRNAs is produced in
ES cells. Indeed, a cluster of piRNA
genes (piRNA cluster) on chromosome
5 was clearly expressed (Supplemental
Fig. S7C). Moreover, the expression of
this piRNA cluster was specifically induced in undifferentiated ES cells (Supplemental Fig. S7C, days 0, 4, 6). As a control,
Sgsm1, the neighboring gene to this
piRNA cluster, showed a slight increase in
expression during differentiation (Supplemental Fig. S7C). Even more strikingly,
Piwil2 (also known as Mili), a mouse
ortholog of the Drosophila PIWI gene, is
expressed in ES cells, and its expression
decreased below a detectable level 4 d after differentiation (Supplemental Fig.
S7D). The consistent inductions of
piRNAs and the Piwil2 gene in undifferentiated ES cells further entertained
the hypothesis that some piRNAs were
produced not only in germ cells.
Figure 3. Predicting genomic features. (A) Distribution of bidirectional promoters in the 55 epigenomic clusters. Fold enrichment indicates the ratio between the percentage of bidirectional promoters in a cluster and the average percentage of all clusters. (*) P < 1060; (**) P < 1090. (B–D)
Accuracies of predicting genomic features as measured by receiver operating characteristic (ROC)
curves. AUC indicates area under the curve. Promoters were predicted by groups 1b, 5, 8, and 12 (P <
2.2 3 1016, Wilcoxon test). Gene bodies were predicted by groups 1a, 4, 10, and 11 (P < 2.2 3 1016).
Bidirectional promoters were predicted by cluster 19 (P < 2.2 3 1016). (Insets) Details of the high
specificity regions. (E ) A predicted bidirectional promoter and a regular promoter. Along a fraction of
chromosome 11, each genomic segment is colored by the cluster it belonged to. The stretch of DNA
belonging to cluster 19 (yellow) corresponded to a bidirectional promoter.

Bidirectional promoters were strongly enriched in group 8
(clusters 19, 12, 48; P = 3.9 3 10290) (Fig. 3A). A simple but
powerful classifier for identifying bidirectional promoters can be
built based on the clusters. Based on whether a genomic segment
belongs to cluster 19, one can reach 80% sensitivity with a specificity of 99.6% (Fig. 3D). Besides bidirectional promoters, miRNA
promoters were also enriched in specific clusters, including cluster 28 (P = 6.96 3 1028, Fisher’s exact test) and cluster 52 (P =
1.51 3 1011, Fisher’s exact test) (Supplemental Fig. S7A). Thus,
through unsupervised clustering, GATE revealed distinct spatiotemporal epigenomic patterns in several specific types of
promoters.
PiRNAs and PIWI proteins were discovered in germ cells
(Thomson and Lin 2009) and were thought to be silenced in ES
cells. Unexpectedly, piRNAs were specifically enriched in cluster 11
(P = 3.08 3 1016, Fisher’s exact test) and cluster 28 (P = 2.05 3
106, Fisher’s exact test) (Supplemental Fig. S7B). As a control, in
cluster 11 where piRNA was strongly enriched (9.53-fold more
enriched than expected), miRNAs were depleted (0.89-fold less
than expected). Thus piRNAs and miRNAs had different temporal epigenomic characteristics. These data suggest that even
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Combinatorial temporal changes
of epigenomic modifications

There were large differences among the
nine epigenomic modifications regarding
their temporal changes. The most stable modification was H3K36me3, which
showed little change in all groups. The
other eight modifications showed clusterspecific temporal changes (Fig. 2).
Gene body groups showed three types of combinatorial
changes. The first type was represented by coordinated decreases of
H3K27ac, H3K4me1/2, H2A.Z, and 5-hmC and an increase in CpG
methylation (Fig. 2, red circles in group 4). These coordinated
epigenomic changes did not clearly influence mRNA expression
(Fig. 2B, mRNA) but were associated with strong up-regulation of
ncRNAs (Fig. 2B, ncRNA). The second combination was decreases
of H3K27ac and H3K4me2/3 (red circles, group 11), which were
associated with down-regulation of both mRNAs and ncRNAs
(orange circles). The third combination was coordinated increases
of H3K4me1/2 and 5-hmC, which corresponded to up-regulation
of ncRNAs (groups 1a and 10).
All promoter groups shared increases of H3K4me1/2, H2A.Z,
5-hmC, and 5-mC together with a decrease in CpG methylation.
Interestingly, this recurrent combinatorial pattern itself was
not sufficient to induce gene expression changes. However,
when this pattern was further combined with a decrease in
H3K4me3, it was associated with down-regulation of ncRNAs
(Fig. 2, group 1b).
Enhancer groups showed four types of combinatorial
changes. The first type was an increase in CpG methylation, which

Spatiotemporal clustering of the epigenome
correlated with down-regulation of ncRNAs (red and orange
circles, group 6). The second combination was an increase in
H3K27ac and decreases in H3K27me3 and 5-mC, which correlated
with up-regulation of mRNAs and ncRNAs. The third type was
coordinated decreases of H3K27ac, H3K4me1/2, H2A.Z, and 5-hmC
together with an increase in 5-mC, which correlated with downregulation of mRNAs and ncRNAs (group 9). The last type was
coordinated decreases of H3K27ac and H3K4me3 together with
a 5-mC increase, which correlated with down-regulation of mRNAs
and ncRNAs (Fig. 2, group 7).
Both transcribed and silenced repeats showed coordinated
decreases in H3K27me3, 5-hmC, and 5-mC (especially non-CpG
methylation [mCpH]), which correlated with up-regulation of
transcription (Fig. 2, ncRNA).

Recurrent themes of epigenomic and transcriptome changes
Recurrent themes appeared in the majority of the spatiotemporal
clusters. These recurring patterns may represent basic properties of
temporal gene regulation by the epigenome.
First, combinatorial epigenomic changes are prevalent. In
every case except one, we observed combinatorial changes of three
to seven epigenomic modifications. Furthermore, different genomic features (promoters, enhancers, genes, and repeats) have different combinations of temporal changes.
Second, combinatorial patterns of epigenomic changes are
predictive of gene expression changes (Fig. 1A, temporal axis).
While gene expression data were not used in clustering epigenomic
data, the epigenomic clusters clearly distinguish gene groups with
different temporal expression changes (Fig. 2).
Third, almost all combinatorial epigenomic changes correspond with changes in ncRNA expression levels. The direction of
ncRNA expression changes was not associated with the changes in
any single epigenomic modification but was strongly predictable
by combinatorial changes (see Fig. 6).
Fourth, epigenomic changes in enhancers instead of
promoters are indicative of mRNA expression changes. This
reconciles previous observations that temporal epigenomic
changes were poorly correlated with gene expression changes
during cell differentiation (Wu et al. 2011b) by reproducing such
results in promoter regions with more epigenomic modifications; but also it points out the importance of epigenomic
changes in enhancers. Consistently, human ChIP-chip analysis showed enhancer associated modifications, including
H3K27ac and H3K4me1, had greater dynamic changes than
other modifications during ES cell differentiation (Hawkins et al.
2011).
Fifth, all assayed modifications except H3K36me3 have
robust temporal changes in multiple genomic features (promoters, enhancers, gene bodies, and repeats). The robust and
recurrent temporal changes appeared not only in genomic regions where the epigenomic modifications were abundant, but
also in genomic regions where the modification levels were
low. Previously, H3K4me1 was associated with enhancers and
H3K4me3 and H2A.Z were associated with promoters due to
their abundance in these regions. However, H3K4me1 showed
reliable changes not only in enhancers, but also in promoters
and gene bodies where its modification level was low. Similarly,
H3K4me3 (group 7) and H2A.Z (group 9) showed reliable
changes in enhancers. These data may suggest regulatory functions of epigenomic modifications in previously ignored genomic regions.

Temporal changes of H3K4me2, mCpH, and H2A.Z
are predictive of DNA hydroxymethylation
It remains unknown what guides TET enzymes to specific parts of
the genome to convert 5-mC to 5-hmC. To explore the upstream
signals that might specify where in the genome 5-mC should be
converted to 5-hmC, we asked if there were any epigenomic
modifications that correlate with 5-hmC in terms of temporal
changes. Across all 55 epigenomic clusters (Fig. 2), the temporal
changes of 5-hmC were on average most correlated with
H3K4me2, uCpG (measured by MRE-seq), H3K4me1, and H2A.Z
(Supplemental Fig. S8). Next, we checked the temporal correlations
between 5-hmC and every other assayed epigenomic mark on
every genomic segment (200-nt window). On 78.1% of the genomic segments, the temporal correlations between 5-hmC and
H3K4me2 were larger than 0.8 (P < 10300) (Supplemental Fig.
S9B). Strong temporal correlations between 5-hmC and uCpG,
5-hmC and H4K4me1, and 5-hmC and H2A.Z were also observed
(Supplemental Fig. S9E,9F). In contrast, H3K4me3 and H3K36me3
did not show large temporal correlations with 5-hmC. By categorizing genomic segments by their clusters, promoter segments
showed the strongest temporal correlations between 5-hmC
and H3K4me2, uCpG, and H2A.Z (Supplemental Fig. S9). These
data indicate strong associations between the di- and monomethylation of H3K4 and hydroxylmethylation of nearby cytosines. The exchange of histone variants H2A and H2A.Z may also
associate with 5-hmC synthesis.
The temporal changes of uCpG and 5-hmC were strongly
correlated (Supplemental Fig. S9K). Two scenarios can fit these
data. First, the uCpG was generated by a cytosine demethylation preprocess that involves the conversion of 5-mC to 5-hmC
(Bhutani et al. 2011). In other words, the same cytosine is converted from 5-mC into 5-hmC and then into C (same cytosine
hypothesis). Alternatively, uCpG signals TET enzymes to the genomic neighborhood to convert neighboring 5-mC into 5-hmC
(neighbor hypothesis). If the same cytosine hypothesis is true, we
would predict that 5-mC and 5-hmC are anti-correlated during ES
cell differentiation. However, temporal changes of 5-mC did not
anti-correlate with 5-hmC changes (Supplemental Fig. S9M). More
genome segments had the same direction of 5-mC changes and
5-hmC changes than expected at random (P < 10200) (Supplemental Fig. S9M, dashed line). These data are inconsistent with the
same cytosine hypothesis. Conversely, TET1 contains a Znf_CXXC
domain that interacts with uCpG, which is in line with the
neighbor hypothesis.
We then explored the roles of mCpH. mCpH was reported in
oocytes without known functions (Tomizawa et al. 2011). These
m
CpHs were presumably due to high levels of de novo methylation
enzymes Dnmt3a/b in oocytes (Lees-Murdock et al. 2005). The
simultaneous increase of 5-mC and decrease of CpG methylation
in the same promoters (see Fig. 6; Supplemental Fig. S4) suggest
de novo mCpH. This is consistent with the increased expression
levels of DMNT3b during guided differentiation of ES cells toward
mesendoderm cells (Supplemental Fig. S9N). Temporal changes of
m
CpH were strongly correlated with 5-hmC changes (Supplemental Fig. S9D), suggesting the genomic segments undergoing
m
CpH were also experiencing hydroxymethylation. Complementary to these data, 5-hmC level was most enriched in low
CpG regions in ES cells (Yu et al. 2012). In summary, temporal
changes of H3K4me1/2, mCpH, and H2A.Z are predictive of 5-hmC
changes throughout the mouse genome. These temporal correlations do not provide any causal information, but they may help to
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prioritize some hypotheses for future biochemical analyses of
5-hmC pathways.

H2A.Z is predictive of gene expression in a context-specific
manner
Epigenomic marks were thought to be predictive of gene expression levels in a context-independent manner (Karlic et al. 2010).
The main support for this idea was that the linear model using
epigenomic marks to predict expression can be learned from CD4+
T cells and then applied to other types of T cells (Karlic et al. 2010).
To see if this theory holds during ES cell differentiation, we correlated the model-learned epigenomic modification levels to gene
expression levels (Supplemental Fig. S10). Consistent with previous thoughts, some epigenomic marks were correlated with
gene expression in a context-independent manner, in the sense
that these correlations persist in different genomic locations (enhancers, promoters, etc.) and in different differentiation states.
Such context-independent epigenomic marks included H3K36me3,
H3K27ac, and 5-mC. However, several epigenomic marks showed
context-specific influence on mRNA expression. Promoter
H3K4me3 was correlated with mRNA expression, but enhancer
H3K4me3 was not (Supplemental Fig. S10). Promoter H2A.Z was
not correlated with mRNA expression in undifferentiated ES
cells (Pearson correlation < 0), but promoter H2A.Z was strongly
correlated with mRNA expression after differentiation (Pearson

correlation = 0.83) (Supplemental Fig. S10, panel H2A.Z). Thus,
epigenomic marks, although associated with gene expression,
can have different directions of association in different cellular
contexts.

A unified model for 5-hmC’s effects on gene expression
The effects of 5-hmC on gene expression remain unclear. The
difficulty of clarifying 5-hmC’s effects lies, at least in part, in the
seemingly conflicting data. On the one hand, promoter 5-hmC
levels were anti-correlated with gene expression levels in both
undifferentiated and differentiated ES cells (Fig. 4A,B; Supplemental Fig. S10, panel 5-hmC). This may suggest 5-hmC as a repressive mark. On the other hand, enhancer 5-hmC had a weak
positive correlation with gene expression (Fig. 4C,D; Supplemental
Fig. S10, panel 5-hmC), which may indicate an activation role. Is
there a simple model that can accommodate all these data and illustrate 5-hmC’s effects on gene expression? We identified a model
by looking at temporal changes of 5-hmC.
5-hmC were concentrated on gene bodies in ES cells and were
shifted to promoters after differentiation (Figs. 4B; Supplemental
Fig. S11). These data are consistent with the recent discovery of
lower 5-hmC in promoters than in intragenic regions in ES cells
(Booth et al. 2012). However, the large increase of promoter 5-hmC
and the decrease of intragenic 5-hmC during ES cell differentiation
were not reported before. Enhancer concentration of 5-hmC was

Figure 4. A unified model showing the effects of 5-hmC on gene expression. (A–B) The average intensities of 5-hmC on predicted promoter groups (A)
and enhancer groups (B) in three time points. Three thousand base pairs (bp) of flanking regions centered on the centers of the genomic segments of each
group are shown. (C,D) The expression levels of nearby genes for predicted promoter groups (C ) and enhancer groups (D). Mean and standard deviation
(error bar) are shown for each time point. Whether 5-hmC increases above a critical threshold (horizontal line, A,B) correlates with the direction of
expression changes. (FPKM) Fragments per kilobase of exon per million fragments mapped.
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increased during differentiation (Fig. 4D). The enrichment of
5-hmC in enhancers and promoters in differentiated cells provides
further support to the hypothesized regulatory role of 5-hmC (Ficz
et al. 2011; Pastor et al. 2011; Stroud et al. 2011; Wu et al. 2011a).
5-hmC showed either a substantial increase or a moderate
increase but showed no decrease in any enhancer clusters or promoter clusters (Fig. 4B, D). In both promoters and enhancers,
a substantial increase of 5-hmC (Fig. 4A, promoter groups 5 and 12,
C, enhancer groups 2, 3, 6) inevitably resulted in induction of gene
expression. When 5-hmC did not substantially increase, nearby
genes would show decreasing expression. This was consistent with
both promoters (group 8) and enhancers (group 9). Similar analyses on MeDIP-seq and MRE-seq data suggest that 5-mC did not
confound the observed effect of 5-hmC on gene expression (Supplemental Fig. S12). Thus, a simple model can explain the relationships between 5-hmC and gene expression during ES cell
differentiation. If 5-hmC increases above a critical value, gene
expression increases; otherwise, gene expression decreases. This
model states an association between 5-hmC and gene expression
changes, and it does not rule out additional epigenomic marks as
confounding factors.

Epigenomic states correlate with transcription networks
The GATE model infers epigenomic states of every genomic segment as undifferentiated (U) or differentiated (D), indicating when
a genomic segment may change its regulatory functions. Thus, the
GATE model provides a genome-wide view of the locations of
regulatory sequences as well as their time of activation. Such information may help to clarify the transcription network (Hawkins
et al. 2011). To explore this potential, we did a case study for three
mesendoderm genes: Fgf 8, Sox17, and Foxa2. A set of group 3 enhancers were found in the introns and 39 intergenic regions of Fgf8
(Fig. 5A, yellow boxes). These enhancers were predicted to shift
from inactive to active epigenomic states (U/D). Transcription
factor binding sites (TFBSs) of GSC and IRF-1 appeared in these
enhancers (Fig. 5B,C). Both GSC and IRF-1 are key regulators of
mesendoderm differentiation (Blum et al. 1992; Bruce et al. 2007).
An isolated enhancer was identified ;50,000 nt upstream of the
Sox17 gene (Fig. 5D; Supplemental Fig. S12). Another enhancer was
found ;7000 nt upstream of the Foxa2 gene (Fig. 5E). By use of
epigenomic data, GATE suggested that both the Sox17 enhancer
and the Foxa2 enhancers shifted from inactive to active states
(Supplemental Fig. S13), which was in line with the increased expression of these genes (Fig. 5D,E, FPKM). A strong FOXA2 TFBS
appeared in the Sox17 enhancer, and a strong SOX17 TFBS appeared
in a Foxa2 enhancer. These data suggest a positive feedback loop
between Sox17 and Foxa2. Coincidently, a peak in a FOXA2 ChIPseq experiment in mouse liver (GEO accession no. GSM427089)
(MacIsaac et al. 2010) colocalized with the GATE-predicted Sox17
enhancer (Supplemental Fig. S14A, yellow bar). This is the strongest
peak (P-value < 106) in the 70,000-nt sequence neighborhood of
the Sox17 gene. Moreover, the predicted FOXA2 TFBS appeared at
the center of this peak (Supplemental Fig. S14A, insert). Reversely,
when Sox17 expression was induced in mouse ES cells, a strong peak
(fold change = 8.1, P < 2.5 3 107) of SOX17 ChIP-chip (GEO accession no. GSM470844) (Niakan et al. 2010) appeared ;7000 nt
upstream of the Foxa2 gene, colocalizing with the GATE-predicted
Foxa2 enhancer (Supplemental Fig. S14B). Moreover, the predicted
SOX17 TFBS located precisely at the center of this peak (Supplemental Fig. S14B, insert). These ChIP-seq/chip data reinforced the
GATE predicted feedback loop. This feedback loop can stabilize the

activation of two master transcription factors and thus may be essential for mesendoderm differentiation.

Discussion
Previous computational methods for analyzing epigenomes relied
primarily on spatial information of epigenomic marks. For example, an HMM model was developed to annotate genomic sequences by colocalization of multiple epigenomic marks (Ernst
and Kellis 2010). GATE connects with the Ernst-Kellis model in
that with only one time point, GATE degenerates into a zero-order
HMM. Unlike the Ernst-Kellis model, though, GATE did not rely
on prior information about the arrangements of genomic features. The unsupervised nature of GATE makes it capable of predicting the genomic features that were not included in a training
process. In the ES cell differentiation process, GATE predicted
bidirectional promoters, miRNA promoters, and piRNA genes
with high accuracies.
Temporal information is as important as spatial information
in studying epigenomic functions. A case in point is that although
TET was known to interact with the trithorax homolog MLL
(Tahiliani et al. 2009), the MLL targets H3K4me1/2 were not pursued as a major clue for guiding TETs to specific genomic regions.
This was probably due to the lack of a very strong spatial correlation between H3K4me1/2 and 5-hmC in any studied cell types.
Indeed, 5-hmC was enriched not only in enhancers where
H3K4me1/2 levels were high, but also in promoters (Yu et al. 2012),
CTCF binding sites (Yu et al. 2012), and gene bodies (Booth et al.
2012) where H3K4me1/2 levels were not necessarily high. However, temporal correlations between H3K4me1/2 and 5-hmC were
particularly strong, in that >85% of the genomic sequences had
the same direction of changes of H3K4me2 and 5-hmC (Supplemental Fig. S9B,E). This result prioritizes H3K4me1/2 and H3K4
methyltransferases as a candidate upstream signal for guiding TETs
to specific parts of the genome.
People questioned uCpG’s capability to attract TET1 (Frauer
et al. 2011), despite TET1 containing a zinc finger CXXC domain
that can bind uCpG (Tahiliani et al. 2009). Indeed, no genomewide mapping has showed strong overlaps of 5-hmC and uCpG.
Furthermore, the information content of CpG is small, making it
hard to believe that such a weak sequence signal can confer specificity to guide TET1. In this study, we reported striking temporal
correlations of 5-hmC and uCpG throughout the genome, highlighting the necessity of analyzing epigenome dynamics and
providing genome-wide data to support the role of uCpG in guiding TET1. TET1’s interacting partner MLL contains a zinc finger
CXXC domain as well. Theoretically, the MLL–TET1–uCpGs three
way interaction can be a lot more stable than a two-way interaction
of a protein and its DNA recognition site (He et al. 2009). This
MLL–TET1–uCpGs interaction is reinforced by MLL’s roles to
methylate H3K4 and interact with methylated H3K4. These analyses provide a model that uCpGs guide TET1 to specific genomic
locations by initiating self-reinforcing uCpGs–MLL–H3K4me1/
2–TET1 interactions.
It remains controversial whether 5-hmC predominantly exists in the CpG context. Stand bias analysis suggested presence of
5-hmC on CpH in ES cells (Ficz et al. 2011). However, this result
was not supported by single-base resolution mapping of 5-hmC
(Yu et al. 2012). We observed positive temporal correlations of
m
CpH and 5-hmC in multiple genomic regions. Two scenarios fit
this observation. First, 5-hmC existed on CpH; alternatively, the
temporal changes of mCpH were associated with 5-hmC changes in
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Figure 5. Predicted mesendoderm enhancers harbor transcription factor binding sites. Epigenomic clusters near the Fgf8 (A), Sox17 (D), and Foxa2 (E )
genes. Genomic segments (colored bars) are marked by their cluster numbers on the left. Their variable widths indicate their activity states. A left-thinright-fat bar indicates a change of the activity states. A strong GSC motif (B) and a strong IRF-1 motif (C ) appeared in predicted enhancer segments in the 39
and the intron of the Fgf8 gene. Both predicted enhancers showed changes of activities during the differentiation (left-thin-right-fat). A strong Foxa2 motif
appeared in a predicted enhancer 50,000 bp upstream of the Sox17 gene (D). In turn, a strong Sox17 motif appeared in a predicted Foxa2 enhancer.
(FPKM) Fragments per kilobase of exon per million fragments mapped.
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nearby CpGs. In promoters, uCpG levels measured by MRE-seq
often increased as 5-hmC levels increased, which suggests that
at least a subset of the newly converted 5-hmC in promoters were on
CpHs. These results suggest perhaps examining differentiated ES
cells may resolve the controversy of the presence of 5-hmC on CpHs.
Modeling and analyzing the temporal data facilitates the
discovery of context-specific functions of epigenomic marks. In
yeast, H2A.Z was associated with both active and inactive genes
(Raisner et al. 2005). In this study, H2A.Z was clearly associated
with active genes in mesendoderm cells but not in undifferentiated
ES cells. This shows the importance of considering the cellular
contexts when inferring the regulation functions of an epigenomic
mark.
Most of the epigenomic marks (all assayed except H3K36me3)
showed robust temporal changes in multiple genomic features,
including promoters, enhancers, gene bodies, and repeats. This
recurring theme can have large implications for studying gene
regulation. In the canonical view, certain modifications are indicative of certain genomic features; for example, H3K27ac and
H3K4me1 are enhancer marks and H3K4me1 is a promoter mark.
This canonical view was built on the observation that these
modifications were a lot more abundant in certain genomic features than others. This view made it tempting to ignore the regulatory roles of modification in places where it is not abundant.
However, the robust temporal changes of many modifications
in their noncanonical (low-abundance) regions, such as H3K27ac
in gene bodies, H3K4me1 in gene bodies and promoters, and
H3K4me3 in gene bodies and enhancers, indicate that they can
play regulatory roles in more genomic features than in the canonical view. Future experiments are needed to test this hypothesis. Consistent with this new view, the temporal epigenomic
changes in low-abundance regions were sometimes correlated with
mRNA or ncRNA expression changes (Figs. 2, 6).
Another dilemma in the epigenomic field is as follows. On the
one hand, epigenomic changes are essential to organismal devel-

opment, supported by the fact that different cell types exhibit
clearly different epigenomic patterns (Hawkins et al. 2010; Ernst
et al. 2011). Thus, the epigenome is expected to regulate gene expression during development and differentiation (Hawkins et al.
2011). However, on the other hand, temporal epigenomic changes
during cell differentiation were reported to not correlate with gene
expression changes (Wu et al. 2011b). Our method and data allow
us to investigate this dilemma from a new perspective.
From the methodological perspective, GATE provides two
advantages. First, the unsupervised clustering summarizes the
combinatorial changes of multiple epigenomic marks. Previously,
one had to compare gene expression changes with every epigenomic mark one-by-one, resulting in inconclusive or even
conflicting results. This was because the association between gene
expression and an epigenomic mark may be confounded by other
epigenomic marks. GATE enables us to correlate gene expression
changes with the combinatorial changes of multiple epigenomic
marks. Second, GATE makes unsynchronized changes in different
parts of the genome comparable. This enables us to effectively pull
information together from different genomic segments with similar but unsynchronized temporal changes.
Consistent with the previous erythroid differentiation study
(Wu et al. 2011b), temporal epigenomic changes did not correlate
with gene expression changes in several GATE clusters. These
clusters were all in promoters (Fig. 2, groups 5, 8, 12). However,
temporal epigenomic changes in enhancer-associated clusters
were clearly correlated with gene expression changes. In particular,
changes in DNA methylation alone were associated with ncRNA
expression change (group 6); changes that involve different combinations of DNA and histone modifications were associated with
both mRNA and ncRNA changes in different directions (Fig. 2,
groups 3, 7, 9); and changes in modifications on repeats were
predictive of repeat expression (groups 13, 14). Including nonuniquely mapped reads into the analysis may impact the results on
repeat regions. These data suggest that the epigenome-mediated

Figure 6. A model for combinatorial epigenomic changes and gene expression. One to several combinatorial patterns (columns) were identified on
each genomic feature. The model-learned intensity levels for each epigenomic mark (input rows) in the undifferentiated state and the differentiated state
are color-coded, and the directions of change are marked by arrows. The corresponding temporal changes of mRNA and ncRNA expression are colorcoded in a green-to-red scale (output rows).
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gene regulation during cell differentiation, although clear in enhancers, may not be discernible in promoters, thus helping to resolve the hitherto mentioned dilemma.

Methods

Indices are as follows: w, genomic segments; t, time points; m,
epigenomic marks; and k, epigenomic clusters. Observed data are
as follows: W, the number of genomic segments; M, the number of
epigenomic marks; T, the number of time points; and v, normalized sequence counts. Note that vw,t,m is the normalized sequence
count for epigenomic mark m in genomic segment w at time t. O is
all the observed data. Hidden variables are as follows: Cw, cluster
membership of the genomic segment w; H, activity states, taking
values 0 or 1. Precomputed parameters are as follows: K, the
number of epigenomic clusters. Model parameters are as follows:
pk, the proportion of genomic segments in cluster k; bi,j, transition
probability from state i to state j; l, the Poisson parameter for
emission probabilities; and L, all the model parameters.

The GATE model is a hierarchical model with two layers (Fig. 1B).
The top layer is a FMM, in which each component of the mixture
represents a cluster of genomic segments that share temporal epigenomic patterns. The bottom layer models the time-course epigenomic data in each cluster. Each cluster is modeled as a HMM
with the hidden states representing the changes of regulatory activities during a differentiation process, which emit the observed
epigenomic data at each time point. Overall, GATE is a finite
mixture of HMMs.

t =1

=

T Y
M
Y



P vw,t ,m Cw , H w,t ; lCw ;
t =1 m=1



vw = v w,1 ,v w,2 ; . . . ,vw,T
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Thus, a generative probabilistic model for all data has been
fully specified.

Likelihood function
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where b = b1 , b2 , . . . ,bK , l = l1 , l2 , . . . , lK :

The top layer
The top layer FMM models the cluster memberships of every
genomic segment. The cluster membership of genomic segment
w is modeled as a categorical distribution with probability p =
(p1,. . .,pK):
K

Cw ; CategoricalðpÞ; and PðCw Þ = +k = 1 PðCw = kÞpk :

ð1Þ

The HMM at the bottom layer
Given the cluster membership Cw , the potential changes of regulatory activities for genomic segment w are modeled as a Markov
chain. As a hidden variable, Hw,t 2 (0,1) represents the activity state
of genomic segment w at time t.


The transition probability matrix bCw is written as



bCi,wj = P H w,t+1 = j H w,t = i,Cw , where i,j 2 ð0,1Þ:

ð2Þ

The conditional probability of Hw given Cw is

 

 YT1 

P H w j bCw ,Cw = P H w,1 j Cw
P H w,t+1  H w,t ,Cw
t =1

 YT1 Cw
b
:
= P H w , 1 j Cw
t = 1 H w,t ,H w,t + 1

ð3Þ

Given the hidden variable, the observed sequence count for
each epigenomic mark is modeled to follow a Poisson distribution
(emission distribution). The Poisson parameter depends on the
cluster membership and the hidden regulatory state.
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Under model assumptions, the likelihood function of observed
data (O) is

The model

Genome Research

ð4Þ
Conditional on the cluster membership and the hidden variable, the different epigenomic marks are modeled as independent,
and thus

The probabilistic model for analyzing temporal epigenomic
data (GATE) symbols
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v w,t ,m ; Poisson lCwH w,t ,m , where 1 # m # M,1 # w # W, 1 # t # T

ð6Þ

Parameter inference
The hidden variables of interest (C, H) were estimated by maximum likelihood estimation. We implemented a nested EM algorithm in which the transition and emission parameters of the
HMM were estimated by a Baum-Welch algorithm (Supplemental
Fig. S1; Supplemental Methods).

Fitting data to the GATE model
For simulation data, the cluster number (K) was estimated by the
Bayesian information criteria (BIC):


BIC ¼ 2 Q LjLðfinalÞ + ð2 3 K  1 + K 3 M 3 2Þ 3 ln ðW Þ,
where L ¼ fb, l, pg is the collection of all parameters:
For real data, we initial run the model with a relatively large
cluster number (55), which was estimated from a previous study.
The model-generated clusters were then merged into larger groups
based on hierarchical clustering (Supplemental Fig. S3). We set the
hidden state at the first time point as 0. We set bC1,w0 = 1  bC1,w1 = 0,
because it is unlikely to make two switches of regulatory states
within this short differentiation time course.

Maintenance of ES cells
Undifferentiated mouse E14 ES cells were cultured under feederfree conditions. ES cells were plated on gelatin-coated dishes with
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Dulbecco’s modified Eagle medium (DMEM; GIBCO), supplemented with 15% heat-inactivated fetal bovine serum (FBS;
GIBCO), 0.055 mM mercaptoethanol (2-ME; GIBCO), 2 mM
L-glutamine, 0.1 mM MEM nonessential amino acid, 5000 units/
mL penicillin/streptomycin, and 1000 units/mL of LIF (Millipore
ESG1107) at 37°C in 5% CO2 (Li et al. 2011).

Antibody–chromatin complexes were captured by protein
A/G Agarose beads (Pierce) and eluted with 1% SDS after extensive
washing. The cross-link between DNA and chromatin proteins was
reversed by incubation in 20 mM NaCl overnight at 65°C. DNA
was purified by QIAquick PCR Purification Kit (Qiagen 28106) and
dissolved into 30 mL TE buffer per immunoprecipitation.

Differentiation of ES cells into mesendoderm

MRE-seq, MeDIP-seq, and 5-hmC-seq

Guided differentiation of ES cells was performed according to the
method previously described (Yasunaga et al. 2005). Briefly, 2 3
105 cells were seeded on Collagen IV–coated 10-cm dishes (BD, 08774-33) in serum-free medium ESF-B (Itochu Corporation), supplemented with 0.1% BSA, 50 mM 2-ME, and 10 ng/mL Activin A
(R&D Systems). The culture medium was changed every day.

MRE-seq and MeDIP-seq were performed according to the method
previously described (Maunakea et al. 2010). Sample DNA was
digested in parallel using HpaII, Hin6I, SsiI (Fermentas), and
HpyCH4IV (New England Biolabs) before deep sequencing.
5-hmC-seq was performed according to the method previously described (Song et al. 2011). 5-hmC was chemically labeled
as selected. Sequencing libraries were constructed using the same
protocol as ChIP-seq (Illumina 2010a).

Reverse transcription polymerase chain reaction
Total RNA was extracted from cells 0, 4, and 6 d after induction of
differentiation with TRIzol Reagent (Invitrogen, 15596-026)
according to manufacturer’s protocol. First-strand cDNA was prepared with M-MLV Synthesis System (New England Biolabs). Betaactin was used as a control. Pluripotency and lineage-specific
marker genes were assayed by the Applied Biosystems 7900HT Fast
Real-Time PCR System. Primer sequences are listed in Supplemental Table S5. Gene expression levels were normalized to the
expression level of beta-actin. Fold changes of gene expression
levels were calculated between day 4 and day 0 and between day 6
and day 0.

Immunostaining
A total of 10,000–20,000 cells were seeded on Collagen IV–coated
35-mm dishes (Ibidi 45074) in the medium used for guided differentiation (ESF-B supplemented with 0.1% BSA, 50 mM 2-ME,
and 10 ng/mL Activin A). Cells were fixed in 4% paraformaldehyde.
Primary antibodies against GSC (Origene, TA500087) and Sox17
(Millipore 09-038) were mixed and applied to the fixed cells for 2 h
at 37°C. The goat anti-mouse IgG antibody conjugated with Alexa
568 (Invitrogen A-11031) and the goat anti-rabbit IgG antibody
conjugated with Alexa 488 (Invitrogen A-11034) were sequentially
applied to the samples, each for 2 h at 37°C, as secondary antibodies.
Cellular nuclei were stained by Hoechst 33342 (Invitrogen, H3570)
for 15 min at room temperature. Images were obtained using the
LSM 700 microscope (Zeiss).

Small RNA sequencing
Total RNA was purified with TRIzol Reagent (Invitrogen 15596026) and used as an input to generate a small RNA library using
True-seq small RNA kit (Illumina RS-200-0012). The RNA 39
adapters in this kit were specifically modified to target miRNAs and
other small RNAs that have a 39 hydroxyl group resulting from
enzymatic cleavage by Dicer or other RNA processing enzymes.
Library products ranging from 145–160 nt were collected and
amplified. The libraries were quantitated by qPCR, and subsequently sequenced on a HiSeq2000 sequencer using TruSeq SBS
sequencing kit version 2 and analyzed with pipeline version 1.8
(Illumina).

Data access
All sequencing data are accessible from the NCBI Gene Expression
Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under SuperSeries accession no. GSE38596.
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Chromatin immunoprecipitation
Cells were fixed with 1% formaldehyde for 10 min at room
temperature. Fixation was inactivated by the addition of 125
mM glycine. Cells were scraped off of dishes and collected by
centrifugation. Cross-linked chromatin–DNA complexes were
isolated from the nuclei lysis buffer and then sonicated into
fragments of a size range between 350 and 600 nt. Specific antibodies listed below were incubated with the solubilized DNA
fragments at 4°C overnight.
Antibodies used in this work are as follows: anti-histone
H2A.Z antibody, ChIP Grade (Abcam, ab4174); anti-histone H3
(mono methyl K4) antibody, ChIP Grade (ab8895); anti-histone
H3 (di methyl K4) antibody [Y47], ChIP Grade (ab32356); anti-histone
H3 (tri methyl K4) antibody, ChIP Grade (ab1012); anti-histone H3 (tri
methyl K4) antibody, ChIP Grade (ab8580); anti-histone H3 (tri
methyl K36) antibody, ChIP Grade (ab9050); anti-histone H3
(acetyl K27) antibody, ChIP Grade (ab4729); anti-H3K27me3 antibody (Millipore, 07-449); and a monoclonal antibody against
5-methylcytindine (Eurogentec, bi-mecy-0100).
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Spatiotemporal clustering of the epigenome reveals rules of dynamic gene regulation
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